Modular Medical Execs Keep Buying Amid FDA Push, Raising Investor Optimism but Dilution Concerns Persist.
Insider buying at Modular Medical shows board confidence in a $4.60‑priced stock, but dilution and weak fundamentals still cap upside potential.
4 minutes to read


